Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alpha waves are neural oscillations in the 8–12 Hz range observed predominantly over parieto-occipital regions during relaxed wakefulness. The individual peak within this band—known as the individual or peak alpha frequency—varies across people and changes with age. Alpha rhythms are generated by synchronous neuronal activity involving both cortical and thalamic circuits but are most prominent in superficial cortical layers. They play roles in inhibiting unused brain areas during rest, coordinating network communication for attention and working memory tasks, and regulating transitions between wakefulness and sleep. While alterations in individual alpha frequency have been associated with aging-related cognitive decline and certain neurological conditions, "brain oscillatory activity at individual alpha frequency" refers to an electrophysiological phenomenon rather than a discrete molecular target suitable for drug development or direct therapeutic intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha wave (individual alpha frequency) (IAF).